Leigh Sibert
Clinical Nurse Specialist · Newark, DENPI 1386749901
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,109 of the $1,695 with a category attached, or 65.5%. 12 manufacturers reported payments, led by Medtronic at 40.7% of the total.
Across 46 payments — averaging $36.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$690
- Novartis$230
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$195
- Pfizer$126
- Heartflow, Inc.$109
- Kestra Medical Technology Services, Inc.$82
- plus $263 from 6 others
Across 1 payment — averaging $125.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$125
What the payments were for
- Consulting fees$53131%
- Food & beverage$1,10965%
- Education$543%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 6 | $690 |
| Novartis | 15 | $230 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $195 |
| Pfizer | 5 | $126 |
| Heartflow, Inc. | 1 | $109 |
| Kestra Medical Technology Services, Inc. | 3 | $82 |
| AstraZeneca | 4 | $78 |
| Johnson & Johnson | 4 | $75 |
| Boston Scientific | 2 | $48 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
| Abbott | 1 | $18 |
| Boehringer Ingelheim | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FFRct$109
How this compares
Too few clinical nurse specialist providers in Delawareto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 125 | $159,404 |
| XareltoRivaroxaban | 54 | $81,428 |
| EntrestoSacubitril/Valsartan | 51 | $67,117 |
| JardianceEmpagliflozin | 31 | $32,593 |
| BrilintaTicagrelor | 13 | $8,918 |
| Dofetilide | 12 | $5,626 |
| Metoprolol Succinate | 280 | $4,266 |
| Atorvastatin Calcium | 261 | $3,842 |
| Rosuvastatin Calcium | 94 | $2,474 |
| Carvedilol | 178 | $2,058 |
| Ezetimibe | 28 | $1,622 |
| Flecainide Acetate | 27 | $1,186 |
| ClopidogrelClopidogrel Bisulfate | 50 | $927 |
| Losartan Potassium | 94 | $884 |
| Amiodarone Hcl | 36 | $737 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $126 | $159,404125 claims |
| Johnson & JohnsonXarelto | $75 | $81,42854 claims |
| NovartisEntresto | $230 | $67,11751 claims |
| Boehringer IngelheimJardiance | $14 | $32,59331 claims |
| AstraZenecaBrilinta | $78 | $8,91813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few clinical nurse specialist providers in Delawareon file to place this against a meaningful peer group, so we don't.
Other clinical nurse specialist in Newark
- Leasha RoyNewark$500
- Marie CassaliaNewark$439
- Sherry VanhoyNewark$190
- Michael SzeligaNewark$62
- Coleen DeverNewark$54
- Anne VillalobosLewes$10K
- Rhonda MontgomeryTownsend$2K
- Michaelene Baker UrbanWilmington$1K
- Dennise WashingtonMilford$676
- Genna ThompsonDover$640
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.